The results, presented in the forest plot (Figure 3A), demonstrated that LDHA mRNA levels could serve as a prognostic molecular marker in patients with adrenocortical carcinoma (ACC), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), Brain lower grade glioma (LGG), LIHC, LUAD, and pancreatic adenocarcinoma (PAAD). This evidence concerns the gene LDHA and cervical squamous cell carcinoma.